$VTIX

Virtuix (VTIX) reported a 3X increase in Omni One orders quarter-to-date, driven by its collaboration with Meta. The company also highlighted progress in defense programs, enterprise sales to Tesla and NASA, and a potential acquisition. VTIX stock rose 0.94% following the news.

Virtuix (VTIX) sold its Omni One systems to the U.S. Department of Veterans Affairs for deployment at the Detroit VA Medical Center. The systems will be evaluated for therapeutic applications and potential use in the VA's nationwide 'VA Immersive' network, which spans over 145 facilities. This sale marks Virtuix's expansion into veteran healthcare and could support wider adoption of its technology.

Virtuix (VTIX) sold Omni One systems to the U.S. Department of Veterans Affairs for deployment at the Detroit VA Medical Center. This marks the company's entry into the VA's healthcare system, which spans over 145 facilities. The sale could represent a significant long-term opportunity for Virtuix's technology in therapeutic applications.

Emerging Growth Research reiterated its Buy-Emerging rating and $9.00 price target for Virtuix (VTIX), citing strong fiscal 2026 results and growth prospects. The company reported 32% sequential revenue growth in Q4 2026, with forecasts of 15% and 290% revenue growth for fiscal 2027 and 2028, respectively. Virtuix launched Omni One for Quest, expanding its market to Meta Quest users, and continues to pursue defense opportunities.

Virtuix Holdings Inc. (VTIX) announced its CEO will present at the H.C. Wainwright conference, highlighting recent momentum and Omni One expansion. The company reported quarterly revenue over 50% above analyst estimates, with growing demand in defense, robotics, healthcare, and enterprise markets.

Virtuix Holdings Inc. sold its first Omni One Enterprise systems to the U.S. Navy's Morale, Welfare and Recreation Liberty Program. The two units, priced at around $15,000 each, will be deployed at a U.S. Naval Station in Europe. This sale could lead to further deployments if successful, as the program has 68 locations globally.

Virtuix (VTIX) sold two Omni One Enterprise systems to the U.S. Navy's MWR Liberty Program for approximately $15,000 each, marking its first sale to the Navy's recreational program. The deployment at a U.S. Naval Station in Europe expands Virtuix's military applications beyond training into recreation, with potential for further deployments across 68 global locations. The company has also secured defense-sector contracts with other U.S. military branches.

Virtuix (VTIX) will showcase its AI-driven Counter-Unmanned Aircraft System (C-UAS) Personnel Trainer at the Maneuver Warfighter Conference, September 15-17. The system, developed with LeadTech, is designed for counter-drone training and is being evaluated by the U.S. Army and Marine Corps. Virtuix has expanded its defense programs across all four major U.S. military branches, with recent funding and research agreements.

Virtuix Inc. (VTIX) launched Omni One for Quest, an omni-directional treadmill for Meta Quest headsets. The product, priced at $2,595 in the U.S., is compatible with Quest 2 and 3 and launches with several popular games. The company aims to expand its market reach and positions the product as a fitness solution for gamers.

Virtuix Holdings Inc. partnered with Sirica Therapeutics to deploy its Omni One platform for autism therapy, aiming to enhance treatment outcomes. The initial deployment includes two systems shipped to a Bay Area center, with plans to expand to 100 Sirica Centers nationwide. Emerging Growth Research reiterated a Buy-Emerging rating and $9.00 price target for Virtuix, citing strong fiscal 2026 performance and growth prospects.